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Abstract
Background: The significance of expression of different mucins in succession of malignant transformation of
colorectal polyps is not determined yet. The aim of the present study was to determine the pattern of expression
of MUC1, MUC2, MUC5AC and MUC6 in colorectal polyps and to evaluate the applicability of using mucin
expression in predicting the extent of malignant transformation in colorectal polyps.
Methods: A total of 454 polyp specimens comprising 36 hyperplastic polyps, 15 serrated adenomas, 258 tubular
adenomas, 114 tubulovillous adenomas, and 31 villous adenomas were included in this study, and were
immunostained for MUC1, MUC2, MUC5AC and MUC6 by using mucin specific antibodies.
Results: MUC1 and MUC6 were absent in all hyperplastic polyps and their expression was higher in serrated and
traditional adenomas. Only 5 cases including 2 serrated adenomas, 1 tubulovillous adenoma, and 2 villous
adenomas stained negative for MUC2. The highest expression of MUC5AC was observed in serrated adenomas
followed by tubular adenomas. Binary logistic regression analysis indicated that positive staining for MUC1, and
MUC6, and negative staining for MUC2 would increase the risk of invasion to mucosa or the muscularis mucosae
in colorectal polyps. Ordinal regression analysis demonstrated a positive association between the level of staining
for MUC1 and risk of being of high configuration/grade in colorectal polyps.
Conclusions: MUC1, MUC2, MUC5AC, and MUC6 have the potential to be used as predictors of malignant
transformation and invasion to mucosa or the muscularis mucosae in colorectal polyps. The most reliable
predictions can be achieved by determining the level of expression of MUC1.
Background
Mucins are high molecular weight glycoproteins that are
produced, stored and secreted by mucosal epithelial
cells [1], and act as the main part of the mucus protect-
ing layer of the gastrointestinal tract. The protective role
of mucins is achieved by the presence of oxygen bonds
that attach the long sugar side-chains of the mucins to
tandem repeat protein structures that are rich with ser-
ine and threonine amino acids [2]. These bonds hinder
the mucin degradation by inhibition of protease activity,
and so preserve the viscosity and density of mucins [2].
Various mucin proteins are encoded by different
MUC genes [3-9]. MUC1 gene is located on chromo-
some 1q21-24 and codes for a transmembrane mucin,
which is rarely expressed in normal colorectal mucosa
[3]. MUC2 gene, which is aboundantly expressed in
colorectal goblet cells, encodes a secretory glycoprotein
[4]. The secretory MUC3 gene product is normally
expressed in colorectal mucosa [4,5]. MUC4 gene
encodes a transmembrane glycoprotein. This gene is
located on chromosome 3q29 and predominates in
intestinal mucosa [6]. MUC5AC gene forms a cluster
on chromosome 11p15.5 with MUC2 gene, and codes
for a secretory mucin in stomach [7]. Similarly, MUC6
gene is typically expressed in stomach [5].
Ag r o w i n gb o d yo fe v i d e n c ea d v o c a t e st h ei d e at h a t
expression of MUC genes and distribution of their pro-
ducts alter dramatically in certain types of colorectal
polyps and neoplasms [2,10]. These alterations take place
through several mechanisms that include aberrant glyco-
sylation of mucin side chains, immunoreactivity of mucin
core peptide, deletion of normally expressed antigens,
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novo appearance of new antigens [2]. The secretion of
MUC2 gene products, for example, is suppressed in non-
mucinous colorectal neoplasms [4,11], or MUC5AC and
MUC6, which are normally absent in colorerectal
mucosa, are expressed de novo in villous and tubulovil-
lous colorectal adenomas [12,13]. MUC1 is also believed
to become upregulated in colorectal cancers (3).
The current consensus classifies majority of the color-
ectal polypoid lesions into three major levels of malignant
transformation: hyperplastic polyps (HPPs), serrated ade-
nomas, and conventional (traditional) adenomas [14-16].
It is not still elucidated, however, which mucin altera-
tions at which stage of malignant transformation take
place or become detectable [17]. For instance, there is a
large body of controversy regarding the alterations of
MUC5AC and MUC6 in colorectal polyps. While these
t w om u c i n sw e r er e p o r t e dp r e v i o u s l yt ob em o r e
expressed in medium size/stage adenomas [12], more
recent data reports MUC5AC to be involved in early
stages of malignant transformation, and MUC6 in final
stages [18].
The main objective of this study was to determine the
extent of expression of MUC1, MUC2, MUC5AC, and
MUC6 in different levels of neoplastic transformation of
colorectal mucosa according to immunohistochemistry
results. Moreover, we aimed at determining the predic-
tive value of mucin expression on the malignant trans-
formation of colorectal polyps.
Methods
Patients
In the present study, polyp specimens of all cases of col-
orectal polyp, who had undergone colonoscopy and
biopsy from 2005 to 2008, were retrospectively studied.
Clinical and demographic data were retrieved from the
available hospital records of Taleghani Hospital, Shahid
Beheshti University, M.C. Colorectal polyps were classi-
fied according to their location as right sided (proximal
to splenic flexure), left sided (distal to splenic flexure),
and rectal.
Hematoxylin and Eosin (H&E) slides and Formalin-
fixed, paraffin-embedded tissue polyp specimens includ-
ing 36 hyperplastic polyps, 15 serrated adenomas, 258
tubular adenomas, 114 tubulovillous adenomas, and 31
villous adenomas were obtained from the archives of
pathology department of Taleghani Hospital, Shahid
Beheshti University, M.C. This classification of polyps
will be referred to as polyp configuration hereafter.
Available H&E slides were examined initially by two
pathologists to recheck the original histological diagno-
sis of specimens. Traditional adenomas were classified
in advance into three categories of mixed adenomatous-
hyperplastic, Low-grade adenomatous, and High-grade
adenomatous polyps according to grade of glandular
dysplasia.
Immunohistochemistry
Tissue samples were sectioned (4 μm), deparaffinized in
xylene, and rehydrated in descending alcohol gradient.
Blocking solution was used to block the endogenous per-
oxidase activity. For antigen retrieval, sections were trea-
ted in advance in boiling citrate buffer (ph 6.0) in
microwave oven. Sections were immunostained and incu-
bated afterwards with primary antibodies for MUC1
(Invitrogen, Clone:VU-4-H5), MUC2 (Invitrogen, Clone:
CCP58), MUC5AC (Invitrogen, Clone:45M1), and MUC6
(Invitrogen, Clone:1G8). Then, slides were treated with
Envision (DAKO, REAL Envision) for 20 minutes. To
visualize immunoreactivity, diaminobenzidine was used
and samples were counterstained with hematoxylin.
Ascending alcohol gradient was used eventually to dehy-
drate the sections.
Specimens were observed by two pathologists. The
level of staining for each mucin was calculated by deter-
mining the percentage of immunostained cells per high
power field, and reported as 0 (no staining), 1+ (up to
30%), 2+ (30-60% of cells stained), 3+ (more than 60%
of cells stained). Clinical and demographic data were
compared according to presence (positiveness) or
absence (negativity) of immunohistochemical staining
for each mucin.
Statistical analysis
Differences of distribution between the categorical vari-
ables were examined with chi-square test and Fisher’s
exact test in case of need. For quantitative variables Stu-
dent’s t-test was employed. Three factors of invasion
status (to mucosa or muscularis mucosae and not
beyond), configuration, and grading of polyps were con-
sidered as indicators of malignant transformation of
polyps. Binary logistic regression analysis, with covari-
ates of gender, age, polyp site, and MUC status (+/-)
included, was performed to estimate the risk of invasion
(as defined earlier) according to mentioned factors. In
case of polyp configuration and grading, ordinal regres-
sion analysis was employed, with factors of expression
level of different mucins, tumor site, and gender
included, in order to generate predictions and evaluate
the importance of mentioned predictor variables. Age
was not included in this model because as a continous
variable it would decrease the reliability of the model.
Reported P values of less than 0.05 were considered to
represent the statistical significance.
Ethical considerations
The present study was undertaken with approval
and under direct supervision of ethics committee of
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eases, affiliated to Shahid Beheshti University, M.C.
Results
The study population comprised 454 patients with mean
age of 59.5 ± 14.61 (range 15-89), and male to female ratio
of 1.48. 34% of polyps were of right colon origin, 50% of
left colon, and 16% of rectum. 36 polyps (7.9%) were
hypersplastic, 15 (3.3%) serrated adenoma, and 403
(88.8%) traditional adenoma. Traditional adenomas
included 258 tubular adenoma specimens, 114 tubulovil-
lous adenomas, and 31 villous adenomas. Invasion (just to
mucosa and muscularis mucosae) was observed only in
traditional adenomas, especially the villous type (Table 1).
IHC results for MUC1, MUC2, MUC5AC, and MUC6
MUC1 was positive in 106 (23.3%) polyps, of which none
was hyperplastic. The expression of MUC1 was signifi-
cantly higher in traditional adenomas than serrated ade-
nomas/hyperplastic polyps (23.5% vs. 7.8%, P = 0.005).
T h em a i nd i f f e r e n c eb e t w e e nt h eM U C 1p o s i t i v ea n d
negative polyps was in the level of neoplastic transforma-
tion (Table 2). Higher levels of MUC1 expression was
also observed among traditional adenomas especially
tubulovillous and villous adenomas (Table 3). Immunos-
taining for MUC2 was positive in 449 cases (98.9%). Only
five cases had negative MUC2 staining, of which 2 were
serrated adenomas, 1 was tubulovillous adenoma, and 2
were villous adenomas (Table 2). In comparison to
hyperplastic polyps, traditional adenomas showed lower
levels of MUC2 expression (Table 3).
MUC5AC was positive in 195 specimens. We could
find no significant difference in distribution of MUC5AC
in different polyps. In general, majority of colorectal
polyps in this study had negative expression of
MUC5AC. The exception, however, were serrated adeno-
mas of which 66% were MUC5AC positive (Table 2).
More than 50% of serrated adenomas had MUC5AC
expression level of 2+ or more (Table 3). In addition,
meanwhile MUC6 was positive in about one third of
tubulovillous adenoma and villous adenomas, it was
negative in all hyperplastic polyps (Table 2). Nonetheless,
no statistical significant could be found for difference of
MUC6 expression level in various polyp types (Table 3).
Moreover, we could find no association between expres-
sion of MUC6 with MUC5AC;i no t h e rw o r d s ,o n l y
24.1% of MUC5AC positive specimens were also positive
more MUC6, and 47% of MUC6 positive specimens, had
also positive immunostaining for MUC5AC (P = 0.354).
Certain patterns of MUC expression were significantly
associated with invasion of polyps to mucosa or muscu-
laris mucosae, including the up-regulation of MUC1
(marginal significance), absence of MUC2, and positive
MUC6 expression (Table 2). Regression analysis, with
covariates of gender, age, polyp site, and MUC status
included, indicated that negative staining for MUC2,
Positive staining for MUC6, and left-sidedness would
increase the risk of mucosal or muscularis mucosae
invasion in colorectal polyps significantly (Table 4).
The ordinal regression analysis indicated that the
described model (see statistical analysis), would give ade-
quate predictions either in case of configuration and
grading (P < 0.001, Chi square = 65.32 and 64.99 respec-
tively). The model with the complementary log-log link
(table 5) shows that the four thresholds of the model
equation were significantly different from zero and sub-
stantially contributed to the values of the response prob-
ability in different configurations. Moreover, the
configuration of polyps was significantly associated with
three covariates: polyp site, and level of expression of
MUC1 and MUC5AC (table 5).
Using the model with the negative log-log link to
build the ordinal regression, the grade of glandular dys-
plasia was found to be significantly associated with the
three variables of expression levels of MUC1 and
MUC2, and polyp site (table 6).
Discussion
MUC1 and MUC2 normally belong to colorectal mucosa;
however, while the expression of MUC1 is a rare occasion
Table 1 invasion
1 status, grading, and site of traditional adenomas
TA
2 TVA
2 VA
2 P value
Invasion 3 (1.2%) 10 (8.8%) 11 (35.5%) <0.0001
Grade <0.0001
Mixed adenomatous-hyperplastic 17 (6.6%) 0% 0%
Low-grade adenomatous 217 (84.1%) 76 (66.7%) 16 (51.6%)
High-grade adenomatous 24 (9.3%) 38 (33.3%) 15 (48.4%)
Polyp Site <0.0001
Right colon 103 (39.9%) 27 (23.7%) 5 (16.1%)
Left colon 118 (45.7%) 64 (56.1%) 21 (67.7%)
Rectum 37 (14.3%) 22 (19.3%) 5 (16.1%)
1 Invasion not beyond mucosa or muscularis mucosae;
2 Abbreviations: TA, tubular adenoma; TVA, tubulovillous adenoma; VA, villous adenoma.
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secretory colorectal mucin [17-21]. MUC5AC and MUC6,
which are gastric mucins, are believed to express de novo
in certain colorectal polyps [12-14].
The pattern of distribution of different mucins described
in this study is in general in accordance with findings of
previous studies in this regard [2,4,12,14,16-21]. While the
highest expression of MUC1, and MUC6 was observed in
villous adenomas, they were totally absent in hyperplastic
polyps. MUC2, in contrast, was completely expressed in
hyperplastic polyps and tubular adenomas, but was absent
in some serrated adenoma, tubulovillous adenoma, and
villous adenoma specimens.
Results of MUC5AC, however, were in favor of previous
studies depicting a higher expression of MUC5AC in mid-
dle stages of malignant transformation [12]. Positive coeffi-
cients for MUC5AC in ordinal regression analysis (table 5)
indicate that increase of MUC5AC expression level does
not increase the likelihood of a polyp to be of villous
adenoma configuration. These results were consistent with
that of table 3, in which expression of MUC5AC was more
prominent in tubular adenoma, and to a lesser extent in
serrated and tubulovillous adenomas.
As is shown in table 2, when it comes to the distribu-
tion pattern of different mucins, serrated adenomas act
as if they rank higher in the sequence of grading and
configuration. This is much more tangible in case of
MUC2 that was absent in 13.3% of serrated adenomas,
and MUC5AC that was present in 66.6% of these cases.
These findings advocate the results reported by some
previous studies regarding the high abnormality of
mucins expression in serrated adenomas [14,18].
Along with determining the pattern of distribution of
mucins in colorectal polyps, the present study benefits
from the added value of ordinal regression analysis as
part of its methodology. The model fitting information
tables indicated that our models would give better pre-
dictions than intercept-only models (see results) [22-24].
Table 2 Clinical and demographic differences of polyps with and without MUC immunoreactivity
MUC1 Staining MUC2 Staining MUC5AC Staining MUC6 Staining
+- +- + - +-
Age
Mean 59.86 59.45 59.55 59.00 59.37 59.67 61.14 59.10
P = 0.803 P = 0.933 P = 0.837 P = 0.231
Gender
Male 72 198 266 4 112 158 61 209
Female 33 150 182 1 83 100 39 144
P = 0.020 P = 0.462 P = 0.491 P = 0.824
Site
Right colon 37 119 154 2 73 83 27 127
Left colon 54 172 224 2 94 132 57 169
Rectum 15 56 70 1 27 44 14 57
P = 0.908 P = 0.975 P = 0.370 0.404
Configuration
Hyperplastic 0 36 36 0 13 23 0 36
Serrated 4 11 13 2 10 5 4 11
TA
1 69 189 258 0 117 141 57 201
TVA
1 21 93 113 1 43 71 28 86
VA
1 12 19 29 2 12 19 11 20
P = 0.001 P < 0.0001 P = 0.182 P = 0.007
Type
Hyperplastic 0 36 36 0 13 23 0 36
Serrated 4 11 13 2 10 5 4 11
Mixed adenomatous-hyperplastic 0 17 17 0 3 14 3 14
Low-grade adenomatous 70 239 309 0 136 173 74 235
High-grade adenomatous 32 45 74 3 33 44 19 58
p < 0.0001 p < 0.0001 P = 0.069 P = 0.021
Invasion
2
% within MUC+/-
9.4% 4% 4.7% 60% 3.6% 6.6% 13% 3.1%
P = 0.029 p < 0.0001 P = 0.161 p < 0.0001
1 Abbreviations: TA, tubular adenoma; TVA, tubulovillous adenoma; VA, villous adenomas;
2 Invasion not beyond mucosa or muscularis mucosae.
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square were non-significant for both models, implying
the well fitting. As no scale component was included,
test of parallel lines assumption was applicable [22], and
yielded significance of less than 0.001 for both models
(not presented in results section).
Given the regression analyses, (binary logistic and ordi-
nal) it is implied that different mucins can provide certain
predictions regarding mucosal and muscularis mucosae
invasion, grading and configuration of colorectal polyps.
In this respect, MUC 2 and 6 were shown to be associated
with invasive behaviour of these polyps. Level of expres-
sion of MUC1 and 5 was associated with the level of con-
figuration, and level of expression of MUC 1 and 2 could
provide predictions on grading of colorectal polyps.
MUC1 exhibited negative regression coefficients in
both of these ordinal regression models, indicating that
polyps that expressed lower levels of immunostaining for
MUC1 were unlikely to rank higher in polyp configura-
tion/grading. Moreover, in binary logistic regression ana-
lysis, a marginally significant association was observed
between the expression of MUC1 and invasion risk. At
the present state of knowledge, these findings do not
imply that MUC1 can be used as a tumor marker. But
based upon these models, one can confidently argue
about the potential applicability of MUC1 expression as a
predictor of malignant transformation, and invasive beha-
vior of colorectal polyps. Negative staining for MUC2
was shown in the binary logistic regression model to be
valuable in predicting the risk of mucosal and muscularis
mucosae invasion in colorectal polyps. In addition, in
ordinal regression analysis, it was shown to reduce the
likelihood of a polyp to be of high grades. Positive expres-
sion of MUC6 increased the risk of invasion (as defined
earlier) significantly; however, no predictions could be
elicited in terms of grading and configuration by using
MUC6.
Applicability of mucins in predicting certain character-
istics of colorectal polyps (invasion, configuration and
grading) evokes the notion that maybe mucins expres-
sion could be employed in predicting the extent of
malignant transformation in colorectal polyps. Future
studies, however, would prove or disprove this hypothe-
tical potential.
In case of polyp site, significant associations were eli-
cited in all of regression models with invasion, grading
and configuration. Given these analyses, beside the
expression status of MUC1, left sidedness of colorectal
polyps corresponded to increased risk of invasion to
mucosa and muscularis mucosae, having high configura-
tion and polyp grading.
Our models had their own limitations too. The major
limitation, which arised from the retrospective nature of
the study, was that data of normal colorectal mucosa
were not included in the statistical models. The fact is
that the pattern of expression of MUC1, MUC2, and
Table 3 Level of expression of different mucins in
colorectal polyps
HPP
1 SA
1 TA
1 TVA
1 VA
1 P value
MUC1 expression
0 36 11 189 93 19 <0.000
1+ 0 3 58 13 2
2+ 0 1 11 8 8
3+ 0 0 0 0 2
MUC2 expression
0 0 2 0 1 2 <0.000
1+ 3 2 32 16 2
2+ 22 6 145 69 15
3+ 11 5 81 28 12
MUC5AC expression
0 23 5 141 71 19 <0.000
1+ 10 2 16 13 10
2+ 2 6 74 27 2
3+ 1 2 27 3 0
MUC6 expression
0 36 11 201 86 20 0.067
1+ 0 3 48 23 8
2+ 0 1 8 5 2
3+ 0 0 1 0 1
1 Abbreviations: HPP, hyperplastic polyps; SA, serrated adenoma; TA, tubular
adenoma; TVA, tubulovillous adenoma; VA, villous adenoma.
Table 4 Regression analysis determining the risk of invasion
1 in colorectal polyps
P value Odds Ratio 95% confidence interval
Lower bound Upper bound
MUC1, negative vs. positive 0.069 0.407 0.155 1.071
MUC2, negative vs. positive 0.002 29.729 3.424 258.140
MUC5AC, negative vs. positive 0.132 2.142 0.794 5.776
MUC6, negative vs. positive 0.001 0.203 0.081 0.506
Gender, female vs. male 0.053 2.503 0.988 6.337
Polyp site, left colon and rectum vs. right colon 0.049 3.834 1.005 1.005
Age
2, 0.335 0.985 0.956 1.015
1 Invasion to mucosa or muscularis mucosae and not beyond;
2age was entered as continuous variable.
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plastic polyps, is identical to what is reported in other
studies for normal mucosa [14,17,18]. However, this does
not hold true for MUC5AC, which indicates that lack of
inclusion of normal mucosa data could have influenced
the regression results of MUC5AC to a larger extent.
The other limitation, arised from the recent concept
that serrated adenomas might go through a different
pathway of malignant transformation [25-28]. Majority
of colorectal polyps can be classified as hyperplastic
polyps, serrated adenomas and traditional adenomas [2].
Owning mixed features of hyperplastic polyps and tradi-
tional adenomas, serrated adenomas were quite recently
introduced as a distinct entity that lies between hyper-
plastic polyps and traditional adenomas in the sequence
of malignant transformation of colorectal polyps [29].
However, more recent data indicate that serrated adeno-
mas can get involved in an alternative carcinogenesis
pathway that does not include traditional adenomas
[25-28]. This could cast a shadow of doubt on the pre-
sumed ordinal hierarchy towards the malignancy that
w a sc o n s i d e r e di nt h i ss t u d yi nt e r m so fg r a d i n ga n d
Table 5 ordinal regression determining the risk of ranking higher in the configuration of colorectal polyps
P value Regression Coefficient 95% confidence interval
Lower bound Upper bound
Threshold
HPP
1 <0.001 -20.295 -22.239 -18.325
SA
1 <0.001 -19.929 -21.864 -17.993
TA
1 <0.001 -17.580 -19.508 -15.658
TVA
1 <0.001 -16.586 -18.506 -14.666
MUC1
0 <0.001 -17.609 -18.075 -17.142
1+ <0.001 -17.810 -18.334 -17.286
2+ - -16.873 -16.873 -16.873
MUC5AC
0 0.008 0.583 0.152 1.014
1+ 0.001 0.865 0.345 1.384
2+ 0.039 0.480 0.024 0.937
Polyp site,
left colon and rectum <0.001 0.417 0.194 0.641
right colon
1 Abbreviations: HPP, hyperplastic polyps; SA, serrated adenoma; TA, tubular adenoma; TVA, tubulovillous adenoma.
Table 6 ordinal regression determining the risk of being of higher grades
P value Regression Coefficient 95% confidence interval
Lower bound Upper bound
Threshold
HPP
1 <0.001 -8.692 -10.818 -6.566
SA
1 <0.001 -8.515 -10.640 -6.391
Mixed adenomatous-hyperplastic <0.001 -8.352 -10.467 -6.228
Low-grade adenomatous <0.001 -5.763 -7.855 -3.670
MUC1
0 <0.001 -6.857 -7.451 -6.263
1+ <0.001 -6.172 -6.807 -5.537
2+ - -5.189 -5.189 -5.189
MUC2
0 0.043 -1.345 -2.651 -0.040
1+ 0.251 .221 -0.156 0.598
2+ 0.682 .052 -0.196 0.299
Polyp site,
Left colon and rectum 0.047 0.237 0.003 0.470
Right colon
1 Abbreviations: HPP, hyperplastic polyps; SA, serrated adenoma.
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knowledge, we preferred to adhere to these two com-
monly used classifications, and not to exclude serrated
adenomas.
Conclusions
To conclude, we think that mucins have the potential
provide predictions on invasive behaviour, grading and
configuration of colorectal polyps. But the predictive
value of various mucins differ based upon what is going
to be predicted. Almost all of mucins that are studied
here can provide predictions on the invasive behavior of
colorectal polyps; however, only MUC1 can provide
such information in respect to both the grading and
configuration of colorectal polyps. Thus, MUC1 is the
most reliable predictor of malignant transformation of
colorectal polyps among the mucins that are studies in
this article.
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